Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Use and Outcome of NovoSeven® Treatment in Severe Postpartum Haemorrhage - Experiences From an Observational Multi-country (UK, DK, FR, NL) Retrospective Cohort Study

NCT04723979 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT04723979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04723979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Use and Outcome of NovoSeven® Treatment in Severe Postpartum Haemorrhage - Experiences From an Observational Multi-country (UK, DK, FR, NL) Retrospective Cohort Study
Lead sponsor
Leiden University Medical Center
Phase
Observational
Overall status
Completed
Start date
May 1, 2020
Completion date
January 31, 2021
Enrollment
3,322 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post partum hemorrhage